A new drug delivery method of bispecific ligand-directed toxins that reduces toxicity and promotes efficacy in a model of orthotopic pancreatic cancer

Схожие документы

• A deimmunized bispecific ligand directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model
  по: Oh, Seunguk, et al.
  Опубликовано: (2012)
• A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
  по: Tsai, Alexander K., et al.
  Опубликовано: (2010)
• Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity
  по: Stish, B J, et al.
  Опубликовано: (2009)
• A novel “reduced immunogenicity” bispecific targeted toxin simultaneously recognizing human EGF and IL-4 receptors in a mouse model of metastatic breast carcinoma
  по: Oh, Seunguk, et al.
  Опубликовано: (2009)
• Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
  по: Oh, Felix, et al.
  Опубликовано: (2018)